The impact of walking impairment, cardiovascular risk factors, and comorbidity on quality of life in patients with intermittent claudication

被引:62
作者
Breek, JC
Hamming, JF
De Vries, J
Henegouwen, DPV
van Heck, GL
机构
[1] Martini Hosp, Dept Surg, NL-9700 RM Groningen, Netherlands
[2] Tilburg Univ, Dept Psychol, NL-5000 LE Tilburg, Netherlands
关键词
D O I
10.1067/mva.2002.124369
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: The objective of this study was to assess the impact of walking impairment, cardiovascular risk factors, and comorbidity on quality of life (QOL) in patients with intermittent claudication (IC). Material and methods: The prospective observational study was conducted in the setting of a vascular outpatient department of a teaching hospital. QOL was assessed in 200 consecutive patients with IC, with a reduced version of the World Health Organization Quality of Life Assessment Instrument-100. The reduced instrument assesses 17 facets of QOL within five domains (Physical and Psychological Health, Level of Independence, Social Relationships, and Environment). Age, gender, degree of IC, risk factors, comorbidity, as recommended by the Society for Vascular Surgery/North American Chapter of the International Society for Cardiovascular Surgery (SVS/ISCVS), and the presence of back, hip, or knee symptoms were analyzed as possible predictors of QOL. Multiple regression analyses were run with each of the QOL facets and domains as dependent variable. A probability value of less than .05 was considered to be statistically significant. Results: Male gender was found to be a predictor of better scores for Energy and Fatigue and for Sleep and Rest. Women had more Negative Feelings. The presence of back, hip, or knee symptoms was a significant predictive value for many aspects of QOL. With more concomitant diseases, patients had lower scores on the facets of Overall QOL and General Health and of Energy and Fatigue and showed more dependence on medication and treatments. The degree of IC, as expressed in the SVS/ISCVS classification, was a statistically significant predictor of QOL on the domain Level of Independence and its facets Mobility, Activities of Daily Living, and Working Capacity and the facets Pain and Discomfort, Sexual Activity, and Transport. Hypertension was the second most important single predictor of QOL in patients with IC. Conclusion: QOL in patients with IC is only partially determined by the severity of walking limitation as expressed in the SVS/ISCVS classification. The significant impact of cardiovascular risk factors and comorbidity and the presence of back, hip, or knee symptoms on QOL should be recognized and taken into account in the treatment policy.
引用
收藏
页码:94 / 99
页数:6
相关论文
共 27 条
  • [21] Exercise therapy for intermittent claudication: A review of the quality of randomised clinical trials and evaluation of predictive factors
    Robeer, GG
    Brandsma, JW
    van den Heuvel, SP
    Smit, B
    Oostendorp, RAB
    Wittens, CHA
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 1998, 15 (01) : 36 - 43
  • [22] Recommended standards for reports dealing with lower extremity ischemia: Revised version
    Rutherford, RB
    Baker, JD
    Ernst, C
    Johnston, KW
    Porter, JM
    Ahn, S
    Jones, DN
    [J]. JOURNAL OF VASCULAR SURGERY, 1997, 26 (03) : 517 - 538
  • [23] INTERMITTENT CLAUDICATION AND SUBSEQUENT CARDIOVASCULAR-DISEASE IN THE ELDERLY
    SIMONSICK, EM
    GURALNIK, JM
    HENNEKENS, CH
    WALLACE, RB
    OSTFELD, AM
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 1995, 50 (01): : M17 - M22
  • [24] *TASC WORK GROUP, 2000, J VASC SURG, V31, pS77
  • [25] Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication
    Whyman, MR
    Fowkes, FGR
    Kerracher, EMG
    Gillespie, IN
    Lee, AJ
    Housley, E
    Ruckley, CV
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 1996, 12 (02) : 167 - 172
  • [26] Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial
    Whyman, MR
    Fowkes, FGR
    Kerracher, EMG
    Gillespie, IN
    Lee, AJ
    Housley, E
    Ruckley, CV
    [J]. JOURNAL OF VASCULAR SURGERY, 1997, 26 (04) : 551 - 557
  • [27] Evaluation of quality of life in sarcoidosis patients
    Wirnsberger, RM
    de Vries, J
    Breteler, MHM
    van Heck, GL
    Wouters, EFM
    Drent, M
    [J]. RESPIRATORY MEDICINE, 1998, 92 (05) : 750 - 756